肉毒杆菌神经毒素镇痛作用的细胞和分子机制:文献综述。

IF 3.5 4区 医学 Q2 CHEMISTRY, MEDICINAL
Saereh Hosseindoost, Seyed Hassan Inanloo, Seyed Khalil Pestehei, Mojgan Rahimi, Reza Atef Yekta, Alireza Khajehnasiri, Maziyar Askari Rad, Hossein Majedi, Ahmad Reza Dehpour
{"title":"肉毒杆菌神经毒素镇痛作用的细胞和分子机制:文献综述。","authors":"Saereh Hosseindoost,&nbsp;Seyed Hassan Inanloo,&nbsp;Seyed Khalil Pestehei,&nbsp;Mojgan Rahimi,&nbsp;Reza Atef Yekta,&nbsp;Alireza Khajehnasiri,&nbsp;Maziyar Askari Rad,&nbsp;Hossein Majedi,&nbsp;Ahmad Reza Dehpour","doi":"10.1002/ddr.22177","DOIUrl":null,"url":null,"abstract":"<p>Botulinum neurotoxins (BoNTs), derived from <i>Clostridium botulinum</i>, have been employed to treat a range of central and peripheral neurological disease. Some studies indicate that BoNT may be beneficial for pain conditions as well. It has been hypothesized that BoNTs may exert their analgesic effects by preventing the release of pain-related neurotransmitters and neuroinflammatory agents from sensory nerve endings, suppressing glial activation, and inhibiting the transmission of pain-related receptors to the neuronal cell membrane. In addition, there is evidence to suggest that the central analgesic effects of BoNTs are mediated through their retrograde axonal transport. The purpose of this review is to summarize the experimental evidence of the analgesic functions of BoNTs and discuss the cellular and molecular mechanisms by which they can act on pain conditions. Most of the studies reviewed in this article were conducted using BoNT/A. The PubMed database was searched from 1995 to December 2022 to identify relevant literature.</p>","PeriodicalId":11291,"journal":{"name":"Drug Development Research","volume":null,"pages":null},"PeriodicalIF":3.5000,"publicationDate":"2024-03-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Cellular and molecular mechanisms involved in the analgesic effects of botulinum neurotoxin: A literature review\",\"authors\":\"Saereh Hosseindoost,&nbsp;Seyed Hassan Inanloo,&nbsp;Seyed Khalil Pestehei,&nbsp;Mojgan Rahimi,&nbsp;Reza Atef Yekta,&nbsp;Alireza Khajehnasiri,&nbsp;Maziyar Askari Rad,&nbsp;Hossein Majedi,&nbsp;Ahmad Reza Dehpour\",\"doi\":\"10.1002/ddr.22177\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>Botulinum neurotoxins (BoNTs), derived from <i>Clostridium botulinum</i>, have been employed to treat a range of central and peripheral neurological disease. Some studies indicate that BoNT may be beneficial for pain conditions as well. It has been hypothesized that BoNTs may exert their analgesic effects by preventing the release of pain-related neurotransmitters and neuroinflammatory agents from sensory nerve endings, suppressing glial activation, and inhibiting the transmission of pain-related receptors to the neuronal cell membrane. In addition, there is evidence to suggest that the central analgesic effects of BoNTs are mediated through their retrograde axonal transport. The purpose of this review is to summarize the experimental evidence of the analgesic functions of BoNTs and discuss the cellular and molecular mechanisms by which they can act on pain conditions. Most of the studies reviewed in this article were conducted using BoNT/A. The PubMed database was searched from 1995 to December 2022 to identify relevant literature.</p>\",\"PeriodicalId\":11291,\"journal\":{\"name\":\"Drug Development Research\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":3.5000,\"publicationDate\":\"2024-03-25\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Drug Development Research\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/ddr.22177\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"CHEMISTRY, MEDICINAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Drug Development Research","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/ddr.22177","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0

摘要

肉毒杆菌神经毒素(BoNTs)源自肉毒杆菌,已被用于治疗一系列中枢和周围神经疾病。一些研究表明,BoNT 对疼痛病症也可能有益。据推测,BoNTs 可通过阻止感觉神经末梢释放与疼痛有关的神经递质和神经炎症因子、抑制神经胶质细胞的活化以及抑制与疼痛有关的受体向神经元细胞膜的传递来发挥镇痛作用。此外,有证据表明,BoNTs 的中枢镇痛作用是通过其轴突逆向运输介导的。本综述旨在总结 BoNTs 镇痛功能的实验证据,并讨论其作用于疼痛状况的细胞和分子机制。本文回顾的大多数研究都是使用 BoNT/A 进行的。我们检索了 1995 年至 2022 年 12 月的 PubMed 数据库,以确定相关文献。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Cellular and molecular mechanisms involved in the analgesic effects of botulinum neurotoxin: A literature review

Botulinum neurotoxins (BoNTs), derived from Clostridium botulinum, have been employed to treat a range of central and peripheral neurological disease. Some studies indicate that BoNT may be beneficial for pain conditions as well. It has been hypothesized that BoNTs may exert their analgesic effects by preventing the release of pain-related neurotransmitters and neuroinflammatory agents from sensory nerve endings, suppressing glial activation, and inhibiting the transmission of pain-related receptors to the neuronal cell membrane. In addition, there is evidence to suggest that the central analgesic effects of BoNTs are mediated through their retrograde axonal transport. The purpose of this review is to summarize the experimental evidence of the analgesic functions of BoNTs and discuss the cellular and molecular mechanisms by which they can act on pain conditions. Most of the studies reviewed in this article were conducted using BoNT/A. The PubMed database was searched from 1995 to December 2022 to identify relevant literature.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
6.40
自引率
2.60%
发文量
104
审稿时长
6-12 weeks
期刊介绍: Drug Development Research focuses on research topics related to the discovery and development of new therapeutic entities. The journal publishes original research articles on medicinal chemistry, pharmacology, biotechnology and biopharmaceuticals, toxicology, and drug delivery, formulation, and pharmacokinetics. The journal welcomes manuscripts on new compounds and technologies in all areas focused on human therapeutics, as well as global management, health care policy, and regulatory issues involving the drug discovery and development process. In addition to full-length articles, Drug Development Research publishes Brief Reports on important and timely new research findings, as well as in-depth review articles. The journal also features periodic special thematic issues devoted to specific compound classes, new technologies, and broad aspects of drug discovery and development.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信